XIGDUO extended release (XR) Post Marketing Surveillance

Trial Identifier: D1691R00001
Sponsor: AstraZeneca
NCTID:: NCT03038789
Start Date: April 2017
Primary Completion Date: August 2019
Study Completion Date: August 2019
Condition: Diabetes: Type 2

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
South Korea ChungCheong, South Korea
South Korea DaeGu, South Korea
South Korea DaeJeon, South Korea
South Korea SunCheon, South Korea
South Korea WonJu, South Korea